Archives

FCT Day 9 So you have a new drug…now what????  Commercialization models Andrew Strong, Hogan Lovells Success Stories Diana Chow, UH; Maksim Mamonkin, BCM; Zhiqiang An, UT Health Funding Cindy [...]

FCT Day 8 Fundamentals of IP, Keisha Hylton-Rodic, Hylton-Rodic Law Tech Transfer Roundtable: Bruce Butler, UT Health; Wei Wan, Texas A&M; Andrew Dennis, MD Anderson Cancer Center Academic vs Industry; [...]

FCT Day 7 Regulatory Round Table, Meredith Tuttle-Brown-Regulatorium;  Lynn Mehler, Hogan Lovells; Mansoor Khan, TAMU, Perspectives on general regulatory issues Human Subject Research, Sujatha Sridhar, UTHealth Roundtable, Mock IRB Session [...]

FCT Day 6 IND Facilitated Discussion, Sean O’Conner, MDA Community Engagement in cancer CTS: Veronica Ajewole, TSU, Jorge Gomez , TAMU

FCT Day 5 Tox Studies: Jeff Larson, Tvardi RTW - PK/PD and Formulation, Dong Liang and Huan Xie, TSU and Diana Chow, UH Preclinical and CMC  Development Panel, Mansoor Khan, [...]

Day 4 Immunotherapy, Yubin Zhou, IBT and Mike Curran, MDA Radiation Therapy, Ahsan Farooqi, MDA Chemoprevention, Robert Chapkin, TAMU Antibody Core,  Zhiqiang An, UTH Chimeric Antigen Receptor T cell (CAR-T) [...]

Day 3 Small molecules: Wenshe Liu, TAMU Cell-based Therapies: Cliona Rooney, BCM Facilitated panel discussion:  Cliona Rooney and Sandhya Sharma, BCM RNA Therapeutics; Roman Sukhovershin, HMRI Synthetic Medicinal Chemistry: Stanton [...]

Foundations of Cancer Therapeutics Day 2 Target Product Profiles (TPP): Rick Silva, TAMU and Jim Liu UT Health TPP participatory activity: Rick Silva , TAMU and Jim Liu, UT Health [...]

FCT Day 1 Welcome and Program Overview: Peter Davies, IBT; Zhiqiang An, UTHealth; Wenshe Liu, TAMU; and Suzanne Tomlinson, GCC Optimizing Your Career in Biotech: Ron DePinho, MDA